SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech News

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tom pope9/14/2009 9:16:37 AM
   of 7143
 
An interesting take on the Pfizer-Bextra affair from the FT - the responsibility of the reps:


Blowing whistles
September 7, 2009 10:57am
by Margaret McCartney

I’ve been kindly pointed toward an interview held a couple of days ago on BBC World Service: Pfizer agrees record fraud fine. John Kopchinski, a Gulf War veteran, was a sales rep for Pfizer who was fired by them after he claimed that one drug, Bextra, was being mis-sold. Pfizer agrees to plead guilty in painkiller case

There were 3,000 reps being asked to do work that was “blatantly illegal” including recommending the drug for acute pain, which it wasn’t licensed for, and at higher doses than what it had been approved for.

The reps were paid fifty dollars for each surgical protocol - proof of prescribing - obtained, despite the fact that this drug wasn’t licensed for use in this setting. It took over 6 years for Kopchinski to expose this, as he has recently done, via the US False Claims Act. Pfizer have to pay $2.3bn in civil and criminal penalties: Kopchinski himself will be awarded over $50m million.

He sounds a very admirable, and brave man. Five other reps were also involved in the lawsuit. This means, though, that approximately 2,994 reps did nothing about what they were hearing about Bextra.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext